ARCHIVES

In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List

This article is from The Cancer Letter archive.

Vol. 18 No. 06 | February 7, 1992

Download PDF Visit The Full Archive

Related Articles

Raub Corrects Record on ALERT

April 20, 1984

Trials Approved by NCI CTEP For the Month of May

May 25, 2012

FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting

March 19, 1976

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990

DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues

January 22, 1988

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011